Learn more

MURAMATSU TAKASHI

Overview
  • Total Patents
    28
About

MURAMATSU TAKASHI has a total of 28 patent applications. Its first patent ever was published in 1985. It filed its patents most often in Japan, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are MELVIN WILLIAM T, JEON SOOK-YEONG and A1M PHARMA AB.

Patent filings per year

Chart showing MURAMATSU TAKASHIs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Muramatsu Takashi 26
#2 Kadomatsu Kenji 12
#3 Ikematsu Shinya 11
#4 Sakuma Sadatoshi 11
#5 Oda Munehiro 10
#6 Muramatsu Hisako 6
#7 Takei Yoshifumi 5
#8 Kumai Hideshi 4
#9 Okamoto Kohji 4
#10 Inoh Kazuhiko 3

Latest patents

Publication Filing date Title
WO2004085642A1 Arthritis-associated gene and use thereof in examining arthritis
WO2004078210A1 Preventive for adhesion following abdominal surgery
JP2004313141A STRONG SUPPRESSION OF EXPRESSION OF HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR USING siRNA
JP2004285037A Trapping of growth factor midkine by lrp partial peptide
JP2004275169A STRONG INHIBITION OF EXPRESSION OF HUMAN MIDKINE BY USING siRNA
JP2004251865A Drug for examining schizophrenia and alzheimer's disease
JP2004012447A Method for diagnosing rheumatism
JP2003210170A Strong inhibition of expression of human midkine using antisense oligonucleotide sequence
JP2003210171A New method for preparing antisense oligonucleotide
JP2002142778A Suppression of expression of midkine using antisense oligonucleotide sequence and suppression of proliferation of cancer cell associated with the same
US7090983B1 Methods for detecting early cancer
EP1097717A1 Remedies for apoptosis-associated diseases
JP2000354487A Midkine receptor
AU6310598A Preventive and therapeutic compositions for drug induced nephropathy and hepatopathy
JPH10168098A Antigenic epitope related to tumor lymph node metastatis
JPS61176534A Contraceptive